The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $49,247.04 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 160 mg vials of the drug Kadcyla, with a completion date of January 17, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group valued at $499,999,999, which allows the DLA to issue firm fixed-price orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has a strong track record of providing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense through its federal contract awards.
Generated 3/30/25, 12:42 AM